O-1656 is an alkylresorcinol-type synthetic cannabinoid which was invented by Billy R Martin and Raj K Razdan at Organix Inc in 2002. It is moderately selective for the CB2 receptor with a CB1 receptor affinity of 18 nM and a CB2 receptor affinity of 2 nM. Since it has a cycloheptyl ring attached to a phenolic core, it falls outside the definition of "cyclohexylphenol derivatives", but may still be controlled substance in some jurisdictions.
See also Abeo-HHC acetate CBD-DMH CP 55,940 Cannabidiol Cannabicyclohexanol Cycloheptyl CP 55,940 O-1871
References


